This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
DOI: Difference between revisions
>Tracer m Added Category:Hallucinogen |
>LockPicker Added legal situation in germany |
||
| Line 134: | Line 134: | ||
{{#ask: [[Category:DOI]][[Category:Experience]]|format=ul|Columns=1}} | {{#ask: [[Category:DOI]][[Category:Experience]]|format=ul|Columns=1}} | ||
Additional experience reports can be found here: | Additional experience reports can be found here: | ||
* [https://www.erowid.org/experiences/subs/exp_DOI.shtml Erowid Experience Vaults: DOI] | |||
*[https://www.erowid.org/experiences/subs/exp_DOI.shtml Erowid Experience Vaults: DOI] | |||
==Toxicity and harm potential== | ==Toxicity and harm potential== | ||
| Line 161: | Line 162: | ||
==Legal status== | ==Legal status== | ||
*'''Austria:''' DOI is illegal to possess, produce and sell under the NPSG (Neue-Psychoaktive-Substanzen-Gesetz Österreich).{{citation needed}} | *'''Austria:''' DOI is illegal to possess, produce and sell under the NPSG (Neue-Psychoaktive-Substanzen-Gesetz Österreich).{{citation needed}} | ||
*'''Australia:''' DOI is not listed as a prohibited substance in The Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP).<ref>Therapeutic Goods Administration. Australian Government Department of Health and Ageing | http://www.comlaw.gov.au/Details/F2013L01607/229bdf2e-7014-4379-b751-0b584f55d699</ref> | *'''Australia:''' DOI is not listed as a prohibited substance in The Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP).<ref>Therapeutic Goods Administration. Australian Government Department of Health and Ageing | http://www.comlaw.gov.au/Details/F2013L01607/229bdf2e-7014-4379-b751-0b584f55d699</ref> | ||
| Line 166: | Line 168: | ||
*'''Canada:''' DOI is listed as a Schedule 1<ref>Canadian Legal Information Institute (CanLII). Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended | http://isomerdesign.com/Cdsa/schedule.php?schedule=1§ion=18.5&structure=C</ref> drug as it is an analogue of amphetamine.<ref>Canadian Legal Information Institute (CanLII). Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended | http://isomerdesign.com/Cdsa/definitions.php?structure=C</ref> The CDSA was updated as a result of the Safe Streets Act changing amphetamines from Schedule 3 to Schedule 1. | *'''Canada:''' DOI is listed as a Schedule 1<ref>Canadian Legal Information Institute (CanLII). Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended | http://isomerdesign.com/Cdsa/schedule.php?schedule=1§ion=18.5&structure=C</ref> drug as it is an analogue of amphetamine.<ref>Canadian Legal Information Institute (CanLII). Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended | http://isomerdesign.com/Cdsa/definitions.php?structure=C</ref> The CDSA was updated as a result of the Safe Streets Act changing amphetamines from Schedule 3 to Schedule 1. | ||
*'''Denmark:''' DOI became illegal on April 8, 2007.{{citation needed}} | *'''Denmark:''' DOI became illegal on April 8, 2007.{{citation needed}} | ||
*'''Germany:''' DOI is controlled under BtMG Anlage II, making it illegal to manufacture, import, possess, sell, or transfer it without a license.<ref>http://www.gesetze-im-internet.de/btmg_1981/anlage_ii.html</ref> | |||
*'''Latvia:''' DOI is a Schedule I controlled substance.<ref>Noteikumi par Latvijā kontrolējamajām narkotiskajām vielām, psihotropajām vielām un prekursoriem (2,5-Dimetoksifeniletānamīni) | http://likumi.lv/doc.php?id=121086</ref> | *'''Latvia:''' DOI is a Schedule I controlled substance.<ref>Noteikumi par Latvijā kontrolējamajām narkotiskajām vielām, psihotropajām vielām un prekursoriem (2,5-Dimetoksifeniletānamīni) | http://likumi.lv/doc.php?id=121086</ref> | ||
*'''Sweden:''' DOI is a Schedule I substance as of August 30, 2007; this was published by the Medical Products Agency in their regulation LVFS 2007:10.<ref>Läkemedelsverkets författningssamling | http://www.lakemedelsverket.se/upload/lvfs/LVFS_2007-10.pdf</ref> | *'''Sweden:''' DOI is a Schedule I substance as of August 30, 2007; this was published by the Medical Products Agency in their regulation LVFS 2007:10.<ref>Läkemedelsverkets författningssamling | http://www.lakemedelsverket.se/upload/lvfs/LVFS_2007-10.pdf</ref> | ||
| Line 173: | Line 176: | ||
==See also== | ==See also== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
*[[Psychedelic]] | *[[Psychedelic]] | ||
| Line 181: | Line 185: | ||
==External links== | ==External links== | ||
*[https://en.wikipedia.org/wiki/2,5-Dimethoxy-4-iodoamphetamine DOI (Wikipedia)] | *[https://en.wikipedia.org/wiki/2,5-Dimethoxy-4-iodoamphetamine DOI (Wikipedia)] | ||
*[https://erowid.org/chemicals/doi/doi.shtml DOI (Erowid Vault)] | *[https://erowid.org/chemicals/doi/doi.shtml DOI (Erowid Vault)] | ||
*[http://isomerdesign.com/PiHKAL/read.php?domain=pk&id=67 DOI (PiHKAL / Isomer Design)] | *[http://isomerdesign.com/PiHKAL/read.php?domain=pk&id=67 DOI (PiHKAL / Isomer Design)] | ||
===Discussion=== | ===Discussion=== | ||
*[http://www.bluelight.org/vb/threads/224091-The-Big-and-Dandy-DOI-Thread The Big & Dandy DOI Thread (Bluelight)] | *[http://www.bluelight.org/vb/threads/224091-The-Big-and-Dandy-DOI-Thread The Big & Dandy DOI Thread (Bluelight)] | ||